In breast cancer tissue we have observed a significant association between the TOP1 copy numbers and the TOP1 mRNA expression (50) which in combination with the frequent amplification of the TOP1 gene suggest that TOP1 gene copy numbers may be clinically relevant as a potential predictive biomarker for irinotecan sensitivity in breast cancer. Here, TOP1 is linked to breast carcinoma.